Allogeneic adipose-derived mesenchymal stem cells (Stemedica Cell Technologies)

N/A

Report date: 2023/11/15 20:04:45

Base Information

Drug NameAllogeneic adipose-derived mesenchymal stem cells (Stemedica Cell Technologies)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemic Stroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesStemedica Cell Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStemedica Cell Technologies Inc
Active IndicationsN/A
Inactive IndicationsIschemic Stroke

Other Information

ATC CodeN/A
Related LinksN/A